Jenburkt Pharmaceuticals Ltd. benchmarking: Perfomance to industry peers

Financial

	Jenburkt Pharma	Medicamen Biotech	Shivalik Rasayan
Operational Metrics
Pharmaceuticals
R&D as a % of Total Sales	0.29 %	n/a	n/a
Financials
5 yr Average ROE	18.49 %	6.92 %	6.54 %
5yr average Equity Multiplier	1.17	1.44	1.82
5yr Average Asset Turnover Ratio	0.88	0.55	0.44
5yr Avg Net Profit Margin	18.1 %	8.69 %	7.94 %
Price to Book	2.49	1.76	0.82
P/E	13.83	45.38	34.08
5yr Avg Cash Conversion Cycle	-32.02 Days	49.75 Days	100.7 Days
Inventory Days	24.72 Days	84.58 Days	80.64 Days
Days Receivable	48.38 Days	139.4 Days	107.04 Days
Days Payable	82.6 Days	264.75 Days	166.18 Days
5yr Average Interest Coverage Ratio	87.2	7.03	8.55
5yr Avg ROCE	24.44 %	10.34 %	8.54 %
5yr Avg Operating Profit Margin	22.46 %	15.51 %	17.6 %
5 yr average Debt to Equity	0.02	0.15	0.2
5yr CAGR Net Profit	14.21 %	-11.57 %	-1.04 %
5yr Average Return on Assets	15.8 %	4.73 %	3.57 %
Shareholdings
Promoter Holding	46.65 %	40.46 %	47.37 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.68 %	-2.75 %	-2.95 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Jenburkt Pharma	Medicamen Biotech	Shivalik Rasayan
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Dermatology 0 Pharmaceuticals Formulations 0 ACTIVE PHARMA INGREDIENT 0 Pharma 0 Agrochemicals 0	Product Wise Break-Up Pharmaceutical 0 Agrochemicals 0 Pharmaceuticals Formulations 100.0 ACTIVE PHARMA INGREDIENT 0 Pharma 0 Dermatology 0	Product Wise Break-Up Pharmaceutical 0 Agro Chemicals 47.29 Pharmaceuticals Formulations 0 ACTIVE PHARMA INGREDIENT 1.55 Pharmaceutical 50.27 Dermatology 0 Others 0.89
Location Wise Break-Up	Location Wise Break-Up India 87.23 Rest of the World 12.56 Others 0.21	Location Wise Break-Up India 20.0 Rest of the World 0 Others 80.0	-